Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 2 | |
Outperform | 5 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 6 analysts offering 12 month price targets for Perspective Therapeutics Inc have a median target of 23.00, with a high estimate of 27.00 and a low estimate of 17.00. The median estimate represents a 70.75% increase from the last price of 13.47.
High | 100.4% | 27.00 |
Med | 70.7% | 23.00 |
Low | 26.2% | 17.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 14, 2024.
Average growth rate | -2.50% |
Average growth rate | +41.86% |
More ▼
Revenue history & estimates in USD
Average growth rate | -27.75% |
Average growth rate | -27.30% |
More ▼